TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.20$ -3.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZYBT
Line item 2021 2022 2023 2024 2025
– +16.7% -3.8% -1.3% -11.5%
– +29.9% -4.1% -13.6% -22.6%
– +55.1% +54.7% +23.4% +170.5%
– +55.1% +67.2% – –
– +31.4% -25.9% -40.1% -69.0%
– +27.1% +5.2% -0.1% -32.7%
– +61.5% -16.2% +39.8% +140.4%
– +28.8% -1.3% -12.4% -7.8%
– +21.2% -1.3% -9.5% -11.4%
– +83.0% +45.5% – –
– +2.2% -42.4% -5.9% +2.4%
– – +0.0% -52.0% +84.4%
– +10.9% -8.0% +4.1% -12.0%
– +55.4% -41.6% +25.5% -144.9%
– +0.0% +0.0% +0.0% +0.4%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?